Predictive Oncology partners with Cvergenx to create new genomics-based AI radiation therapy

--News Direct--

Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence (AI).

Vennare said the objective of this collaboration will be to leverage Predictive Oncology’s drug discovery, AI and machine learning capabilities with the Cvergenx precision genomics radiation therapy platform.

Contact Details

Proactive US

+1 347-449-0879

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/predictive-oncology-partners-with-cvergenx-to-create-new-genomics-based-ai-radiation-therapy-151675745

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.